Jiangsu Hengrui Pharmaceuticals Co., Ltd. (1276N)
BMV
Closed
Oct 6, 2026
Day's Range
104.6452 wk Range
104.64Profile - 1276N - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Profile
Mic Code
XMEX
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
20.60K
Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative medicines. Its current portfolio spans oncology, cardiovascular and metabolic diseases, autoimmune conditions, pain management, anti-infectives, and other therapeutic areas, reflecting a broad presence across major treatment categories. The company is also known for offering surgical drugs, contrast agents, and interventional imaging solutions, supporting both hospital-based care and specialty medicine use. Jiangsu Hengrui Pharmaceuticals Co., Ltd. operates as a research-driven drug developer with a diversified pipeline and a strong emphasis on high-quality products for unmet medical needs. In the financial markets, it is recognized as a leading Chinese pharmaceutical group with a significant role in innovative drug development and commercialization across domestic and international healthcare markets.
Profile Details
Type
Common Stock
Address
No. 38, Huanghe Road
City
Lianyungang
Zip
222047
Country
China
Phone
86 40 0828 3900
Cross Listings - 1276N - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Also listed on
The same company trading on other exchanges.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
